Iranian Gastro Intestinal Cancer
The first seminar on Gastrointestinal cancer updates was held on May 23 , 2024 in Sari city with the presence of great professors of hematology and oncology, radio-oncology specialists, gastroenterology specialists, etc. The main focus of this gathering was the investigation of new treatment methods in relation to gastrointestinal cancer. Actero sponsored this event align […]
Actero company’s gratitude to the country’s nurses on International Nurses Day
May 12th is celebrated as International Nurses Day, in order to appreciate nurses from all over the world. Actero Company has always appreciated the efforts of the country’s dear nurses, for this reason, on this day, express our gratitude to these honorable people.
Holding a Futsal match by Actero Company
Today, the role of exercise in reducing the risk of some cancers is not hidden from anyone. Exercise has many biological effects on the body. These include: decrease in the level of sex hormones such as estrogen and growth factors that are related to the development and progression of cancer. Physical activity can be helpful […]
The presence of Actero company in the 8th Radio Oncology Congress
The 8th International Congress and the 18th Annual Conference of Clinical Oncology was held on 24-26 January 2024 with the presence of scientific groups, specialists, assistants and experts in the field of oncology in Tehran’s Olympic Hotel. The main topics of this conference included oncology, medical physics, radiation therapy technology, radiobiology and oncology nursing. Actro […]
Actero’s presence at The ESMO 2023 Congress
The ESMO Congress is a highly influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. ESMO 2023 has released its latest data, provided high quality training and excellent networking opportunities for oncologists and other stakeholders from all around the world. Actero company participated in this event […]
Actero’s presence at The EANO 2023 Congress
EANO Congress is an European multidisciplinary congress in the field of neuroscience and oncology, which is held every year in one of the European countries. By supporting the presence of physicians in this international congress, Actero Company fulfilled its responsibility in order to achieve new findings and improve the level of treatment of patients.
Actero’s presence at the 5th Annual Congress of Urinary Tract Cancers
The annual multidisciplinary Uro-oncology Congress was held on 06-08 September 1402 by the Genitourinary Tract Cancer Research Center. In this national congress, about 600 specialists from the fields of urology, pathology, radio-oncology and medical oncology were presented and exchanged information and experiences in this field. also veterans and active philanthropists in the field of genitourinary […]
EHA 2023 Actero Sponsorship
Actero company sponsored hematology oncology specialists in European Hematology Association, Being one of the most important event in the field of hematology in order to have more access to the latest scientific update.
Xalico
How to use Xalico: Administer Xalico in combination with fluorouracil and leucovorin every 2 weeks. For adjuvant treatment, continue treatment for up to 12 cycles or unacceptable toxicity. For advanced colorectal cancer, continue treatment until disease progression or unacceptable toxicity. Day 1 Administer Xalico 85 mg/m2 as an intravenous infusion over 120 minutes and leucovorin […]
Evacim
How to use Evacim: Administer only as an intravenous (IV) infusion. Do not administer as an intravenous push or bolus. Do not initiate Evacim until at least 28 days following major surgery. Administer Evacim after the surgical incision has fully healed. First infusion: Administer infusion over 90 minutes. ·Subsequent infusions: Administer second infusion over 60 […]